T, O., GW, R., K, M., A, Z., KC, S., RG, F., . . . I, A. (2026). Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL. Blood advances. https://doi.org/10.1182/bloodadvances.2026020707
Chicago Style (17th ed.) CitationT, Othman, et al. "Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL." Blood Advances 2026. https://doi.org/10.1182/bloodadvances.2026020707.
MLA (9th ed.) CitationT, Othman, et al. "Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL." Blood Advances, 2026, https://doi.org/10.1182/bloodadvances.2026020707.
Warning: These citations may not always be 100% accurate.
